PM
NVO

Parametrica Management’s Novo Nordisk NVO Stock Holding History

Parametrica Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,200
Closed -$825K – 33
2023
Q2 		$825K Sell
10,200
-19,800
-66% -$1.62M 1.59% 20
2023
Q1 		$2.39M Buy
30,000
+2,200
+8% +$156K 4.31% 9
2022
Q4 		$1.88M Buy
+27,800
New +$1.63M 3.86% 10

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parametrica Management's NVO Position: Q3 2023 in Review

Parametrica Management sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 10,200 shares — an estimated $825K sold.

Parametrica Management first reported a position in NVO in Q4 2022 and held it in 3 quarters. The position peaked at $2.39M in Q1 2023. 1,308 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Parametrica Management reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Parametrica Management sold 10,200 Novo Nordisk shares in Q3 2023, an estimated $825K.
  • Parametrica Management first reported a position in Novo Nordisk in Q4 2022 and held it in 3 quarters.
  • Parametrica Management's Novo Nordisk position peaked at $2.39M in Q1 2023.
  • 1,308 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Parametrica Management's 13F filing for Q3 2023, filed 31 Oct 2023.